FGFR4 and colorectal carcinoma: Its therapeutic potential was further assessed in xenograft models, and alterations in downstream signaling were analyzed via Western blot.<h4>Results</h4>FGFR4 emerged as a key regulator of CRC CSC proliferation, migration, and tumorigenic capacity.